Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- SMIT +22.6%, (thinly traded), NDSN +10.3%.
Other news:
- IMUC +119.2% (achieved a key milestone in its research-stage Stem-to-T-Cell immuno-oncology program),
- MBOT +22.5% (announces the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance covering the Company's TipCAT technology platform),
- PSDV +10.4% (reports positive Phase 1 Knee Osteoarthritis pain study data),
- MYO +8.5% (modestly rebounding from 13% two day decline),
- GLUU +7.5% (attributed to new game launch),
- DPW +7.5% (following today's 21% move higher),
- TEVA +7.2% (unveils restructuring plan and additional measures to improve business and financial performance),
- VERU +7.1% (after closing near highs - up 40% on the day),
- MARK +6.7% (announced that China ShenHua Energy Company has selected KanKan as its artificial intelligence technology partner),
- HMNY +3.8% (after closing down 33% on the day),
- CMCM +2.6% (Cheetah Mobile and Microsoft announce collaboration to incorporate Microsoft's AI into Cheetah's product matrix; official version will be released January 2018),
- BBBY +2.5% (following PIR earnings),
- UBS +1.2% UBS AG announces changes to Group Executive Board, new Group Chief Operating Officer named).
Analyst comments:
- GWPH +4.1% (upgraded to Buy from Neutral at Goldman),
- FINL +2.5% (upgraded to Hold from Sell at Deutsche Bank),
- LULU +2.4% (upgraded to Buy from Hold at Deutsche Bank),
- LPSN +1.4% (initiated with a Buy at B. Riley FBR, Inc.; tgt $16.50),
- KEY +1.3% (upgraded to Overweight at Stephens),
- COP +1.2% (upgraded to Buy from Neutral at Goldman),
- NAT +0.8% (upgraded to Hold from Underperform at Jefferies),
- ELY +0.8% (initiated with a Overweight at JP Morgan; tgt $18).